RxDoctor Payments Data

Gregory Bonner

Fort Lauderdale, FLNPI 1932211224

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,512 of the $4,036 with a category attached, or 87.0%. 20 manufacturers reported payments, led by AbbVie at 39.7% of the total. Reporting peaked in 2021 at $1,343 and has fallen 64.2% since, to $481 in 2022.

$4,037in general payments, 2019–2025

Across 248 payments — averaging $16.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Braintree Laboratories, Inc.$493
  • Johnson & Johnson$431
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$369
  • Gilead$325
  • Pfizer$152
  • plus $661 from 14 others

What the payments were for

  • Food & beverage$3,51287%
  • Education$3629%
  • Gifts$1624%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Where these figures come from

Is this you, or does something look wrong? →